Liquidia Return on Equity

Liquidia (LQDA) currently reports a ROE of 58.84%. That is above the Healthcare sector average of 29.33%. Use the charts on this page to explore Liquidia's ROE history and peer comparisons.

Liquidia's ROE of 58.84% is higher than the Healthcare sector average of 29.33%. That is roughly 100.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Liquidia's current 58.84% should be judged against Healthcare norms (sector average: 29.33%) and against LQDA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 58.84%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Liquidia, and consider following LQDA for alerts when major investors trade the stock.

Liquidia is classified in the Healthcare sector. On ROE, it currently shows 58.84% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LQDA with unrelated industries.